Evidence map›Paper›PMID 33582797›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2021

Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death.

Tom E Verstraelen, Marit van Barreveld, Pascal H F M van Dessel, Lucas V A Boersma, Peter-Paul P H M Delnoy, Anton E Tuinenburg, Dominic A M J Theuns, Pepijn H van der Voort, Gerardus P Kimman, Erik Buskens and 33 more

Abstract read
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Prognostic value of late gadolinium enhancement cardiac MRI for ICD therapy in non-ischaemic cardiomyopathy : A 5-year cohort study.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2025
    Article
  10. Review
  11. Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of Cardiology.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2024
    Review
  12. Article
  13. Article
  14. Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  15. The R″ wave in V1 and the negative terminal QRS vector in aVF combine to a novel 12-lead ECG algorithm to identify slow conducting anatomical isthmus 3 in patients with tetralogy of Fallot.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Article
  16. Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohort.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2023
    Article
  17. Review
  18. Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a need or not?Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors.

Tom E VerstraelenDepartment of Cardiology, Amsterdam UMC, Location AMC, University of Amsterdam, Heart Center, Amsterdam, the Netherlands.ORCID 0000-0002-4340-6815
Marit van BarreveldDepartment of Cardiology, Amsterdam UMC, Location AMC, University of Amsterdam, Heart Center, Amsterdam, the Netherlands.ORCID 0000-0002-4672-2477
Pascal H F M van DesselDepartment of Cardiology, Thorax Center Twente, Medisch Spectrum Twente, Enschede, the Netherlands.ORCID 0000-0002-8332-3336
Lucas V A BoersmaDepartment of Cardiology, Amsterdam UMC, Location AMC, University of Amsterdam, Heart Center, Amsterdam, the Netherlands.ORCID 0000-0003-4591-4220
Peter-Paul P H M DelnoyDepartment of Cardiology, Isala Klinieken, Zwolle, the Netherlands.
Anton E TuinenburgDivision of Heart and Lungs, Department of Cardiology, University Medical Centre, Utrecht, the Netherlands.
Dominic A M J TheunsDepartment of Cardiology, Erasmus MC, Rotterdam, the Netherlands.
Pepijn H van der VoortDepartment of Cardiology, Catharina Ziekenhuis Eindhoven, Eindhoven, the Netherlands.
Gerardus P KimmanDepartment of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands.
Erik BuskensDepartment of Epidemiology, University Medical Centre Groningen, Groningen, the Netherlands.
Michiel HullemanDepartment of Cardiology, Amsterdam UMC, Location AMC, University of Amsterdam, Heart Center, Amsterdam, the Netherlands.
Cornelis P AllaartDepartment of Cardiology, Amsterdam UMC, Location VUMC, Vrije Universiteit, Amsterdam, The Netherlands.
Sipke StrikwerdaDepartment of Cardiology, Amphia Hospitals, Breda, the Netherlands.
Marcoen F ScholtenDepartment of Cardiology, Thorax Center Twente, Medisch Spectrum Twente, Enschede, the Netherlands.
Mathias MeineDivision of Heart and Lungs, Department of Cardiology, University Medical Centre, Utrecht, the Netherlands.
René AbelsDepartment of Cardiology, Haga hospitals, the Hague, the Netherlands.
Alexander H MaassDepartment of Cardiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Mehran FirouziDepartment of Cardiology, Maasstad hospital, Rotterdam, the Netherlands.
Jos W M G WiddershovenDepartment of Cardiology, Elisabeth Tweesteden Hospital Tilburg, Tilburg, the Netherlands.
Jan EldersDepartment of Cardiology, Canisius Wilhelmina hospital, Nijmegen, the Netherlands.
Marco W F van GentDepartment of Cardiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
Muchtiar KhanDepartment of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
Kevin VernooyDepartment of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC+), Maastricht, the Netherlands.ORCID 0000-0002-8818-5964
Robert W GraussDepartment of Cardiology, Haaglanden Medical Center, The Hague, the Netherlands.
Raymond TukkieDepartment of Cardiology, Spaarne Gasthuis, Haarlem, the Netherlands.
Lieselot van ErvenDepartment of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
Han A M SpierenburgDepartment of Cardiology, Sint Franciscus Vlietland Group, Schiedam, the Netherlands.
Marc A BrouwerDepartment of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.
Gerard L BartelsDepartment of Cardiology, Martini hospital, Groningen, the Netherlands.
Nick R BijsterveldDepartment of Cardiology, Flevo Hospital, Almere, the Netherlands.
Alida E Borger van der BurgDepartment of Cardiology, Medical Center Leeuwarden, Leeuwarden, the Netherlands.
Mattheus W VetDepartment of Cardiology, Scheper Hospital, Emmen, the Netherlands.
Richard DerksenDepartment of Cardiology, Rijnstate Hospital, Arnhem, the Netherlands.
Reinoud E KnopsDepartment of Cardiology, Amsterdam UMC, Location AMC, University of Amsterdam, Heart Center, Amsterdam, the Netherlands.
Frank A L E BrackeDepartment of Cardiology, Catharina Ziekenhuis Eindhoven, Eindhoven, the Netherlands.
Markus HardenDepartment of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany and DZHK (German Center for Cardiovascular Research), Partnersite, Göttingen, Germany.ORCID 0000-0003-2533-9396
Christian SticherlingDepartment of Cardiology, University Hospital Basel, University of Basel, Switzerland.
Rik WillemsDepartment of Cardiovascular Sciences, University Hospitals Leuven, University of Leuven, Leuven, Belgium.ORCID 0000-0002-5469-9609
Tim FriedeDepartment of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany and DZHK (German Center for Cardiovascular Research), Partnersite, Göttingen, Germany.ORCID 0000-0001-5347-7441
Markus ZabelDepartment of Cardiology and Pneumology-Heart Center, University of Göttingen Medical Center, Göttingen, Germany.ORCID 0000-0003-0895-4602
Marcel G W DijkgraafDepartment of Clinical Epidemiology, Biostatistics and Bio-informatics, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, the Netherlands.
Aeilko H ZwindermanDepartment of Clinical Epidemiology, Biostatistics and Bio-informatics, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, the Netherlands.
Arthur A M WildeDepartment of Cardiology, Amsterdam UMC, Location AMC, University of Amsterdam, Heart Center, Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThis study was performed to develop and externally validate prediction models for appropriate implantable cardioverter-defibrillator (ICD) shock and mortality to identify subgroups with insufficient benefit from ICD implantation. METHODS AND

resultsWe recruited patients scheduled for primary prevention ICD implantation and reduced left ventricular function. Bootstrapping-based Cox proportional hazards and Fine and Gray competing risk models with likely candidate predictors were developed for all-cause mortality and appropriate ICD shock, respectively. Between 2014 and 2018, we included 1441 consecutive patients in the development and 1450 patients in the validation cohort. During a median follow-up of 2.4 (IQR 2.1-2.8) years, 109 (7.6%) patients received appropriate ICD shock and 193 (13.4%) died in the development cohort. During a median follow-up of 2.7 (IQR 2.0-3.4) years, 105 (7.2%) received appropriate ICD shock and 223 (15.4%) died in the validation cohort. Selected predictors of appropriate ICD shock were gender, NSVT, ACE/ARB use, atrial fibrillation history, Aldosterone-antagonist use, Digoxin use, eGFR, (N)OAC use, and peripheral vascular disease. Selected predictors of all-cause mortality were age, diuretic use, sodium, NT-pro-BNP, and ACE/ARB use. C-statistic was 0.61 and 0.60 at respectively internal and external validation for appropriate ICD shock and 0.74 at both internal and external validation for mortality.

conclusionAlthough this cohort study was specifically designed to develop prediction models, risk stratification still remains challenging and no large group with insufficient benefit of ICD implantation was found. However, the prediction models have some clinical utility as we present several scenarios where ICD implantation might be postponed.

Indexed as

Defibrillators, ImplantableAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsCohort StudiesDeath, Sudden, CardiacHumansPrimary PreventionRisk FactorsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsImplantable cardioverter-defibrillatorMortalityPrediction modelsPrimary preventionRisk factorsSudden cardiac death

Identifiers

PMID33582797
PMCPMC8184225

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.